Gw Pharma ADR (GWPH) 82.28 $GWPH GNC Holdings Hit by

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 9:01 AM

Gw Pharma ADR (GWPH) 82.28 $GWPH

GNC Holdings Hit by Dismal Q2 Results, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
GWPH: 82.28 (+0.53), GNC: 20.81 (-0.22), QDEL: 21.74 (-0.03), LNTH: 9.95 (+0.45)

Medtronic Posts Positive Long-term Data for Micra Pacemaker
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:00AM CDT
Medtronic's (MDT) Micra TPS also successfully reduced the risk of patient hospitalization by 47% and risk of system revisions by 82%
MDT: 87.00 (+0.02), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), LNTH: 9.95 (+0.45)

Boston Scientific's Innovation & Emerging Market Raise Hope
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:08AM CDT
On Aug 31, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).
BSX: 24.33 (+0.51), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), LNTH: 9.95 (+0.45)

NuVasive: Strong Q2 Results, Overseas Holds Solid Prospect
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:13AM CDT
NuVasive (NUVA) posted strong results in the second quarter of 2016, with both earnings and revenues squarely beating the Zacks Consensus Estimate
GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), LNTH: 9.95 (+0.45), NUVA: 66.06 (+0.59)

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 82.28 (+0.53), PAHC: 25.59 (+1.32), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59)

Medtronic on Track with Covidien Synergy, Buys HeartWare
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:02AM CDT
On Aug 26, 2016, we issued an updated research report on Medtronic plc (MDT).
MDT: 87.00 (+0.02), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59)

Hill-Rom (HRC) Hits New 52-Week High on Solid Q3 Results
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:08AM CDT
Shares of Hill-Rom (HRC) rallied to a new 52-week high of $59.45 on Aug 26.
GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59), HRC: 59.75 (+0.50)

Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:29PM CDT
Medtronic plc (MDT)'s reported financial results for first-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate.
MDT: 87.00 (+0.02), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59)

TG Therapeutics (TGTX) Catches Eye: Stock Jumps 9.2%
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:00AM CDT
TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares rise over 9% on the day.
GWPH: 82.28 (+0.53), TGTX: 6.51 (+0.16)

Will GW Pharmaceuticals (GWPH) Crush Estimates at Its Next Earnings Report?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:00AM CDT
GW Pharmaceuticals has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
GWPH: 82.28 (+0.53)

Medtronic's HeartWare Takeover Complete for $1.1 Billion
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:54AM CDT
With HeartWare in its kitty, Medtronic (MDT) will now gracefully lead the global VAD market for heart failure patients.
MDT: 87.00 (+0.02), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), HTWR: 58.20 (+0.22), NUVA: 66.06 (+0.59)

Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.28 (+0.53), PAHC: 25.59 (+1.32), BAX: 46.18 (-0.55), QDEL: 21.74 (-0.03)

The Growth of the Legal and Medical Marijuana Markets
PR Newswire - Tue Aug 23, 8:57AM CDT
The legal marijuana market in the United States is projected to grow substantially in 2016. A recent report by New Frontier and ArcView Market Research projected the marijuana market in the United States to grow to $7.1 billion in 2016, which represents a 26% growth comparing to 2015. Veritas Pharma Inc. (OTC: VRTHF), Cara Therapeutics Inc (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech Corp. (TRTC), GW Pharmaceuticals PLC (NASDAQ: GWPH)
CARA: 5.38 (-0.04), GWPH: 82.28 (+0.53), ZYNE: 8.57 (+0.09)

Illumina Rallies on Rumors of Takeover by Thermo Fisher
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:42AM CDT
Reportedly, Thermo Fisher (TMO) has made an all-stock offer of $30 billion to acquire Illumina (ILMN), which currently has a market cap of over $25 billion.
GWPH: 82.28 (+0.53), TMO: 150.95 (-1.24), QDEL: 21.74 (-0.03), ILMN: 168.56 (+0.22)

Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.45 (-0.02), GWPH: 82.28 (+0.53)

Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 4:32PM CDT
Insys Therapeutics, Inc. (INSY) announced that it has enrolled the first patient in a phase II trial on its pharmaceutical cannabidiol (CBD) product candidate.
INSY: 14.36 (+0.09), GWPH: 82.28 (+0.53), CORT: 5.35 (+0.02), PCRX: 40.37 (+0.74)

Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), BRKR: 22.44 (+0.08), NUVA: 66.06 (+0.59)

Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:30AM CDT
On Aug 16, 2016, we issued an updated research report on Phibro Animal Health Corporation (PAHC).
GWPH: 82.28 (+0.53), PAHC: 25.59 (+1.32), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59)

Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:27AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) announced the buyout of CD Diagnostics, an immunoassays and biomarker testing developer.
ZBH: 128.35 (-1.26), GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), NUVA: 66.06 (+0.59)

GW Pharmaceuticals Enters Oversold Territory (GWPH)
MarketNewsVideo.com - Tue Aug 16, 12:38PM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
GWPH: 82.28 (+0.53)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trimble's AI Tool Tackles Chronically Delayed Projects

Facing Down Delays with Trimble's New AI Tool In an industry where timelines are often more of a suggestion than a rule, Trimble's dropping a new hammer with its Connect Scheduling solution. This isn't your garden-variety update; it's a full-fledged assault on the inefficiencies plaguing construction scheduling today. With Trimble Connect Scheduling, folks on the ground...

PrimeFlight Welcomes CEO Amath Fall for Global Growth

A New Era Begins at PrimeFlight On a cloudy November morning in Sugar Land, Texas, some interesting news broke out of PrimeFlight Aviation Services. They've made what seems like a pivotal move by appointing Amath Fall as their new Chief Executive Officer, effective immediately. As PrimeFlight continues to elbow its way into new market territory, having someone like Fall...

LG Wins CES Honor with Breakthrough Battery Diagnostic Tech

Speeding Up Diagnostics: A Major Leap Forward In a world where every second counts, LG Energy Solution strikes gold with their latest innovation, Re.Pulse. CES Innovation Awards 2027 has honored LG for this slick piece of tech that trims down battery diagnosis time from a snail's pace seven hours to a lightning-fast 10 minutes. It's not just about speed—it’s also...

Tom Hanks' New Campaign Boosts Veterans' Morale

Coffee and Kindness: Tom Hanks' Salute to Veterans Alright, let's dive right into the steaming pot that is Tom Hanks' latest venture, shall we? The man who’s charmed us on screen is stirring up another kind of magic off it. Hanks For Our Troops, his coffee company, is launching a campaign aptly named "(T)HANKS"—a nationwide blitz to honor and empower our veterans this...

Ebix Relaunches A.D.A.M. SmartCare Platform for Clinicians

Revolutionizing Patient Education with SmartCare When you're in the thick of things, juggling a half-dozen patients with different needs all in a day’s work, you want your tools to be as fast and straightforward as a greasy spoon diner breakfast—simple, satisfying, and utterly dependable. And Ebix is betting they've cooked up just the recipe for that with their...

Millrose Faces Class Action Over Misleading Investors

Millrose Properties Steps Into Legal Hot Water Ah, stocks and legal squabbles—a pairing as old as Wall Street itself. Now, folks, it seems Millrose Properties, Inc. has stepped right onto the chopping block with a lawsuit knocking on their door over claims they misled investors. The suits from the DJS Law Group aren't mince words: we're talking alleged violations of the...

Human Development Fund's Bold Partnership for Growth

An Unusual Alliance with Far-Reaching Implications Every once in a while, a nonprofit steps up with a move that makes even the toughest investors take notice. This isn't some Wall Street ticker talk, sure, but it’s worth turning your chair toward the table. The Human Development Fund (HDF) has penned a strategic deal with the Islamic Development Bank (IsDB), putting its...

Orthodontic Treatment: Timelines and Expert Insights

Getting Straight to the Point: Orthodontic Timelines Remember that time your teen self thought braces would be over in a flash? Yeah, well, Dr. Judith Okun might have a few words on that. When it comes to braces, you better buckle up for the long haul. Most folks are looking at a solid two years, give or take. No magic shortcuts here, just solid orthodontic science. The...

Veterans Hit Sales Milestones in Nexion Travel Program

Veterans Carve New Paths in Travel Entrepreneurship Nexion Travel Group is giving veterans and military spouses a different kind of battleground—one where the prize isn't a medal, but a successful travel business. With their Veterans in Travel program, they've hit milestones that deserve more than just a polite nod. Surpassing Last Year's Benchmarks Let's cut to the...

ResMed Faces Probe: Potential Breach Alert for Investors

Cracks Surfacing at ResMed? Alright, folks, ResMed Inc. (NYSE: RMD) is facing a bit of heat these days. We're talking about a shareholder alert as Levi & Korsinsky, noted legal hounds when it comes to financial misconduct, have decided to dig deep into ResMed. They're looking to uncover any possible breaches of fiduciary duties by some of the top brass at this sleep apnea...